Trademark Overview
On Wednesday, August 2, 2023, a trademark application was filed for GENERATE BIOMEDICINES with the United States Patent and Trademark Office. The USPTO has given the GENERATE BIOMEDICINES trademark a serial number of 98113061. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Friday, July 5, 2024. This trademark is owned by Generate Biomedicines, Inc.. The GENERATE BIOMEDICINES trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:
Downloadable computer software for use in the pharmaceuticals and healthcare fields, namely, for molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity; downloadable artificial intelligence software for use in the pharmaceuticals and healthcare fields for molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity in connection with pharmaceutical drug discovery and development; downloadable artificial intelligence software for use in the field of healthcare for molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity
Pharmaceutical therapeutic preparations, pharmaceutical preparations, medical therapeutics in the nature of pharmaceutical preparations, therapeutic vaccines, and prophylactic vaccines, and medical pharmaceutical preparations in the fields of oncology, infectious disease, virology, cardiology, allergy, immunology, rheumatology, endocrinology, pulmonology, gastroenterology, and dermatology for treating infectious diseases, cancer, asthma, chronic obstructive pulmonary disease, atopic dermatitis, chronic rhinosinusitis with nasal polyps, inflammatory bowel disease, allergic disease, inflammatory disease, respiratory inflammation or fibrosis, cardiovascular diseases, gout, obesity, neurological conditions, and Sjögren's syndrome, all of the aforesaid developed using artificial intelligence technology
Providing online non-downloadable computer software for use in the pharmaceuticals and healthcare fields, namely, for molecular research, research and development of pharmaceutical products and chemical compounds, cell analysis, design of chemical structures, and analysis of biological or chemical activity; providing online non-downloadable artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in connection with pharmaceutical drug discovery, drug development, pharmaceutical market access, chemogenomics, toxicogenomics and drug response prediction; providing online non-downloadable self-learning and artificial intelligence software for use in the field of healthcare for pharmaceuticals and healthcare fields, namely, for molecular research, research and development of pharmaceutical products and chemical compounds, cell analysis, design of chemical structures, and analysis of biological or c...
